ERBB2 and metastatic neoplasm: An essential observation was that the significant discordance of HER2 status between primary and metastatic tumors among patients with primary HER2-low or HER2-zero tumors, highlighting the importance of reevaluating the HER2 status of relapse or metastatic biopsies.